EGFR and breast carcinoma: We have recently demonstrated a high concordance of SISH and FISH results in the detection of EGFR copy number alterations in lung cancer samples and we have provided data that SISH is an accurate method for the evaluation of the Her2 gene amplification status in cytologic breast cancer specimens, particularly in metastatic breast cancer lesions [16], [17].